Description
Why It’s Done:
This test is important for:
• Guiding targeted antifungal therapy by determining which antifungal drug is most effective.
• Identifying resistance in fungal pathogens, especially in chronic or recurrent infections.
• Managing infections in immunocompromised patients, where effective treatment is critical.
• Supporting decisions when patients do not respond to initial antifungal therapy.
• Monitoring emerging resistance trends in clinical settings.
It is often used in cases of invasive fungal infections, onychomycosis, aspergillosis, or candidiasis, especially when standard treatment fails or in high-risk patients.
Preparation:
• No specific preparation is required from the patient.
• The test is performed on the fungal isolate grown from a previously collected sample (e.g., blood, tissue, sputum, skin).
• No direct sample from the patient is needed for this specific test—rather, it uses the fungal culture obtained from prior testing
